Drug maker tests new compound in healthy volunteers
NCT ID NCT07030127
Summary
This early-stage study tested a new drug called LY3985863 in healthy Chinese volunteers to check its safety and how the body processes it. Twenty-four participants received injections under their skin or a placebo, and researchers monitored for side effects and measured drug levels in the blood. The main goal was to gather basic safety information before testing the drug in people with medical conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital
Beijing, 100191, China
Conditions
Explore the condition pages connected to this study.